Preclinical observations showed that PD-L1 upregulation on several types of tumor cells or DCs suppressed NK cell-mediated tumor cell lysis, and blockade of PD-1 restored NK cell anti-tumor activity and inhibited tumor growth (141, 142). Here, PDCD1 is linked to neoplasm.